PL3033103T3 - Sposoby poprawy objawów astmy przy zastosowaniu benralizumabu - Google Patents
Sposoby poprawy objawów astmy przy zastosowaniu benralizumabuInfo
- Publication number
- PL3033103T3 PL3033103T3 PL14836392T PL14836392T PL3033103T3 PL 3033103 T3 PL3033103 T3 PL 3033103T3 PL 14836392 T PL14836392 T PL 14836392T PL 14836392 T PL14836392 T PL 14836392T PL 3033103 T3 PL3033103 T3 PL 3033103T3
- Authority
- PL
- Poland
- Prior art keywords
- benralizumab
- methods
- asthma symptoms
- improving asthma
- improving
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361864950P | 2013-08-12 | 2013-08-12 | |
| EP14836392.2A EP3033103B1 (en) | 2013-08-12 | 2014-08-07 | Methods for improving asthma symptoms using benralizumab |
| PCT/US2014/050122 WO2015023508A2 (en) | 2013-08-12 | 2014-08-07 | Methods for improving asthma symptoms using benralizumab |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3033103T3 true PL3033103T3 (pl) | 2019-10-31 |
Family
ID=52448839
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL19162585T PL3536339T3 (pl) | 2013-08-12 | 2014-08-07 | Sposoby poprawy objawów astmy przy zastosowaniu benralizumabu |
| PL14836392T PL3033103T3 (pl) | 2013-08-12 | 2014-08-07 | Sposoby poprawy objawów astmy przy zastosowaniu benralizumabu |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL19162585T PL3536339T3 (pl) | 2013-08-12 | 2014-08-07 | Sposoby poprawy objawów astmy przy zastosowaniu benralizumabu |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US9441047B2 (pl) |
| EP (3) | EP3988114A1 (pl) |
| JP (2) | JP6803229B2 (pl) |
| KR (1) | KR102337601B1 (pl) |
| CN (2) | CN105451761A (pl) |
| AU (3) | AU2014306960B2 (pl) |
| BR (1) | BR112016002462A8 (pl) |
| CA (1) | CA2918050C (pl) |
| DK (2) | DK3536339T3 (pl) |
| ES (2) | ES2901634T3 (pl) |
| HK (1) | HK1221647A1 (pl) |
| HU (2) | HUE045402T2 (pl) |
| MX (1) | MX368474B (pl) |
| PL (2) | PL3536339T3 (pl) |
| RU (1) | RU2728578C2 (pl) |
| SG (1) | SG11201600484TA (pl) |
| TR (1) | TR201910413T4 (pl) |
| WO (1) | WO2015023508A2 (pl) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6746496B2 (ja) * | 2013-08-12 | 2020-08-26 | アストラゼネカ アクチボラグ | ベンラリツマブを使用して喘息患者の努力肺活量を増大させる方法 |
| JP6746495B2 (ja) | 2013-08-12 | 2020-08-26 | アストラゼネカ アクチボラグ | ベンラリツマブを使用して喘息の増悪率を低減する方法 |
| RU2706729C2 (ru) * | 2013-10-15 | 2019-11-20 | Астразенека Аб | Способы лечения хронической обструктивной болезни легких с использованием бенрализумаба |
| BR112016008576B1 (pt) | 2013-10-24 | 2023-03-07 | Astrazeneca Ab | Formulações aquosas estáveis de anticorpos e forma farmacêutica de dosagem unitária |
| HK1255922A1 (zh) | 2015-11-04 | 2019-09-06 | Astrazeneca Ab | 二肽基肽酶-4和骨膜素作为嗜酸性粒细胞疾病中嗜酸性粒细胞靶向治疗药物临床反应的预测因子 |
| US20180056018A1 (en) * | 2016-08-31 | 2018-03-01 | Cephalon, Inc. | Inhalation Systems, Devices and Methods |
| TW202214692A (zh) * | 2020-06-05 | 2022-04-16 | 瑞典商阿斯特捷利康公司 | 治療患有鼻瘜肉的患者的重度氣喘之方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6018032A (en) | 1995-09-11 | 2000-01-25 | Kyowa Hakko Kogyo Co., Ltd. | Antibody against human interleukin-5-receptor α chain |
| US6746839B1 (en) * | 1998-01-12 | 2004-06-08 | Interleukin Genetics, Inc. | Diagnostics and therapeutics for an obstructive airway disease |
| EP2264166B1 (en) | 1999-04-09 | 2016-03-23 | Kyowa Hakko Kirin Co., Ltd. | Method for controlling the activity of immunologically functional molecule |
| CA2402477A1 (en) | 2000-02-15 | 2001-08-23 | Kyowa Hakko Kogyo Co., Ltd. | Eosinophil-specific apoptosis inducer |
| US6946292B2 (en) | 2000-10-06 | 2005-09-20 | Kyowa Hakko Kogyo Co., Ltd. | Cells producing antibody compositions with increased antibody dependent cytotoxic activity |
| US8093357B2 (en) | 2002-03-01 | 2012-01-10 | Xencor, Inc. | Optimized Fc variants and methods for their generation |
| CA2542042A1 (en) | 2003-10-08 | 2005-04-21 | Kyowa Hakko Kogyo Co., Ltd. | Antibody composition specifically binding to il-5 receptor |
| US20060014680A1 (en) | 2004-07-13 | 2006-01-19 | Caiding Xu | Peptides and compounds that bind to the IL-5 receptor |
| CA2624189A1 (en) | 2005-10-03 | 2007-04-12 | Xencor, Inc. | Fc variants with optimized fc receptor binding properties |
| CA2685222C (en) | 2007-05-14 | 2017-12-19 | Medimmune, Llc | Methods of reducing eosinophil levels |
| KR101615420B1 (ko) | 2010-12-16 | 2016-04-26 | 제넨테크, 인크. | Th2 억제에 관한 진단 및 치료 |
| EP2710370A4 (en) * | 2011-05-18 | 2015-01-07 | Medimmune Llc | METHODS OF DIAGNOSING AND TREATING PULMONARY DISEASES OR DISORDERS |
| KR20140097217A (ko) * | 2011-11-01 | 2014-08-06 | 메디뮨 엘엘씨 | 급성 천식 악화의 빈도 및 중증도를 감소시키는 방법 |
| JP6746496B2 (ja) * | 2013-08-12 | 2020-08-26 | アストラゼネカ アクチボラグ | ベンラリツマブを使用して喘息患者の努力肺活量を増大させる方法 |
| JP6746495B2 (ja) | 2013-08-12 | 2020-08-26 | アストラゼネカ アクチボラグ | ベンラリツマブを使用して喘息の増悪率を低減する方法 |
-
2014
- 2014-08-07 EP EP21188229.5A patent/EP3988114A1/en not_active Withdrawn
- 2014-08-07 PL PL19162585T patent/PL3536339T3/pl unknown
- 2014-08-07 EP EP14836392.2A patent/EP3033103B1/en active Active
- 2014-08-07 WO PCT/US2014/050122 patent/WO2015023508A2/en not_active Ceased
- 2014-08-07 CA CA2918050A patent/CA2918050C/en active Active
- 2014-08-07 US US14/454,149 patent/US9441047B2/en active Active
- 2014-08-07 CN CN201480044052.7A patent/CN105451761A/zh active Pending
- 2014-08-07 HK HK16109789.8A patent/HK1221647A1/zh unknown
- 2014-08-07 ES ES19162585T patent/ES2901634T3/es active Active
- 2014-08-07 JP JP2016534616A patent/JP6803229B2/ja active Active
- 2014-08-07 MX MX2016001195A patent/MX368474B/es active IP Right Grant
- 2014-08-07 TR TR2019/10413T patent/TR201910413T4/tr unknown
- 2014-08-07 BR BR112016002462A patent/BR112016002462A8/pt not_active Application Discontinuation
- 2014-08-07 HU HUE14836392A patent/HUE045402T2/hu unknown
- 2014-08-07 CN CN202010449449.1A patent/CN111617244A/zh active Pending
- 2014-08-07 PL PL14836392T patent/PL3033103T3/pl unknown
- 2014-08-07 DK DK19162585.4T patent/DK3536339T3/da active
- 2014-08-07 SG SG11201600484TA patent/SG11201600484TA/en unknown
- 2014-08-07 EP EP19162585.4A patent/EP3536339B1/en active Active
- 2014-08-07 AU AU2014306960A patent/AU2014306960B2/en active Active
- 2014-08-07 DK DK14836392.2T patent/DK3033103T3/da active
- 2014-08-07 ES ES14836392T patent/ES2740355T3/es active Active
- 2014-08-07 RU RU2016108734A patent/RU2728578C2/ru active
- 2014-08-07 HU HUE19162585A patent/HUE057065T2/hu unknown
- 2014-08-07 KR KR1020167006565A patent/KR102337601B1/ko active Active
-
2020
- 2020-02-28 JP JP2020032499A patent/JP2020100653A/ja not_active Withdrawn
- 2020-04-16 AU AU2020202564A patent/AU2020202564A1/en not_active Abandoned
-
2023
- 2023-08-10 AU AU2023214323A patent/AU2023214323A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201506401B (en) | Process for producing hydrocarbons | |
| IL235512A0 (en) | New methods | |
| PT3083958T (pt) | Métodos de integração genómica | |
| GB201217018D0 (en) | Methods | |
| HUE038344T2 (hu) | Eljárás szénhidrogének elõállítására | |
| SG11201600481UA (en) | Methods for reducing exacerbation rates of asthma using benralizumab | |
| GB2473409B (en) | Cloud-based de-duplication | |
| GB201700075D0 (en) | Methods to reduce gas carry-uder for cyclonic seperators | |
| SG11201600484TA (en) | Methods for improving asthma symptoms using benralizumab | |
| SG11201601807XA (en) | Methods for treating chronic obstructive pulmonary disease using benralizumab | |
| GB2507760B (en) | Methods | |
| GB201219816D0 (en) | Improving local context search results | |
| GB201208874D0 (en) | Methods | |
| PT2914574T (pt) | Processo novo | |
| GB201322992D0 (en) | New Process | |
| GB201204280D0 (en) | Methods | |
| GB201317756D0 (en) | New process | |
| GB201313211D0 (en) | New process | |
| GB201209689D0 (en) | Methods | |
| GB201316651D0 (en) | Asthma | |
| GB201220686D0 (en) | Methods | |
| GB201208963D0 (en) | Methods | |
| GB201208756D0 (en) | Methods | |
| TWI562827B (en) | Method for making adsorbent | |
| IL236547A0 (en) | Methods to improve male fertility |